Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
303
-
Total 13F shares, excl. options
-
53,546,003
-
Shares change
-
+848,867
-
Total reported value, excl. options
-
$8,404,252,298
-
Value change
-
+$117,845,526
-
Put/Call ratio
-
61.1%
-
Number of buys
-
173
-
Number of sells
-
-135
-
Price
-
$156.95
Significant Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q2 2018
382 filings reported holding BLUE - BLUEBIRD BIO INC - COM as of Q2 2018.
BLUEBIRD BIO INC - COM (BLUE) has 303 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53,546,003 shares
.
Largest 10 shareholders include FMR LLC (7,517,890 shares), Capital Research Global Investors (6,139,530 shares), BAILLIE GIFFORD & CO (4,843,399 shares), VANGUARD GROUP INC (4,196,547 shares), WELLINGTON MANAGEMENT GROUP LLP (2,949,440 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,825,093 shares), BlackRock Inc. (2,735,175 shares), Capital World Investors (2,493,755 shares), Capital International Investors (1,129,709 shares), and STATE STREET CORP (975,963 shares).
This table shows the top 303 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.